Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in doses of 100,000 IU every two weeks significantly reduced disease activity ...
A study conducted at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) in Brazil has shown that low-dose vitamin D supplementation can increase the effectiveness of ...
High-dose vitamin D reduced disease activity in early MS and CIS compared with placebo. Patients taking vitamin D had a longer time to disease activity: 432 days versus 224 days. No severe adverse ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results